|
|
||||||||
1 Division of Pediatric Cardiology, Columbia University, College of Physicians and Surgeons, New York, New York 10032; Departments of 2 Physiology and 3 Pathology, New York Medical College, Valhalla, New York 10595; 4 Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520; and 5 Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts 02115
Statin drugs can upregulate
endothelial nitric oxide (NO) synthase (eNOS) in isolated endothelial
cells independent of lipid-lowering effects. We investigated the effect
of short-term simvastatin administration on coronary vascular eNOS and
NO production in conscious dogs and canine tissues. Mongrel dogs were
instrumented under general anesthesia to measure coronary blood flow
(CBF). Simvastatin (20 mg · kg
1 · day
1) was
administered orally for 2 wk; afterward, resting CBF was found to be
higher compared with control (P < 0.05) and
veratrine- (activator of reflex cholinergic NO-dependent coronary
vasodilation) and ACh-mediated coronary vasodilation were enhanced
(P < 0.05). Response to endothelium-independent
vasodilators, adenosine and nitroglycerin, was not potentiated. After
simvastatin administration, plasma nitrate and nitrite
(NOx) levels increased from 5.22 ± 1.2 to 7.79 ± 1.3 µM (P < 0.05); baseline and
agonist-stimulated NO production in isolated coronary microvessels were
augmented (P < 0.05); resting in vivo myocardial
oxygen consumption (M
O2) decreased from
6.8 ± 0.6 to 5.9 ± 0.4 ml/min (P < 0.05);
NO-dependent regulation of M
O2 in
response to NO agonists was augmented in isolated myocardial segments
(P < 0.05); and eNOS protein increased 29% and eNOS
mRNA decreased 50% in aortas and coronary vascular endothelium.
Short-term administration of simvastatin in dogs increases coronary
endothelial NO production to enhance NO-dependent coronary vasodilation
and NO-mediated regulation of M
O2.
statins; coronary vasodilation; myocardial oxygen consumption
This article has been cited by other articles:
![]() |
Y. Birnbaum, Y. Lin, Y. Ye, R. Merla, J. R. Perez-Polo, and B. F. Uretsky Pretreatment With High-Dose Statin, But Not Low-Dose Statin, Ezetimibe, or the Combination of Low-Dose Statin and Ezetimibe, Limits Infarct Size in the Rat Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2008; 13(1): 72 - 79. [Abstract] [PDF] |
||||
![]() |
A. Bulhak, J. Roy, U. Hedin, P.-O. Sjoquist, and J. Pernow Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3158 - H3163. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. McNulty, B. J. Robertson, M. A. Tulli, J. Hess, L. A. Harach, S. Scott, and L. I. Sinoway Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease J Appl Physiol, May 1, 2007; 102(5): 2040 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Zucker Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure Hypertension, December 1, 2006; 48(6): 1005 - 1011. [Full Text] [PDF] |
||||
![]() |
T. Nagaoka, A. Takahashi, E. Sato, N. Izumi, T. W. Hein, L. Kuo, and A. Yoshida Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol, May 1, 2006; 124(5): 665 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kass Ventricular Arterial Stiffening: Integrating the Pathophysiology Hypertension, July 1, 2005; 46(1): 185 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Weinberg, M. Scherrer-Crosbie, M. H. Picard, B. A. Nasseri, C. MacGillivray, J. Gannon, Q. Lian, K. D. Bloch, and R. T. Lee Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1802 - H1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. McNulty, N. King, S. Scott, G. Hartman, J. McCann, M. Kozak, C. E. Chambers, L. M. Demers, and L. I. Sinoway Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1057 - H1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Jacobson, S. M. Dudek, K. G. Birukov, S. Q. Ye, D. N. Grigoryev, R. E. Girgis, and J. G. N. Garcia Cytoskeletal Activation and Altered Gene Expression in Endothelial Barrier Regulation by Simvastatin Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 662 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tailor, D. J. Lefer, and D. N. Granger HMG-CoA reductase inhibitor attenuates platelet adhesion in intestinal venules of hypercholesterolemic mice Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1402 - H1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van der Harst, A. A. Voors, D. J. van Veldhuisen, J. K. Liao, K. Node, M. Fujita, M. Hori, and M. Kitakaze Short-Term Statin Therapy and Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy * Response Circulation, February 10, 2004; 109 (5): e34 - e34. [Full Text] [PDF] |
||||
![]() |
M. Varela and J. L. Garvin Acute and Chronic Regulation of Thick Ascending Limb Endothelial Nitric Oxide Synthase by Statins J. Am. Soc. Nephrol., February 1, 2004; 15(2): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-N. Trochu, S. Mital, X.-p. Zhang, X. Xu, M. Ochoa, J. K Liao, F. A Recchia, and T. H Hintze Preservation of NO production by statins in the treatment of heart failure Cardiovasc Res, November 1, 2003; 60(2): 250 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sasaki, S. Bharwani, P. Jordan, T. Joh, K. Manas, A. Warren, H. Harada, P. Carter, J. W. Elrod, M. Wolcott, et al. The 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitor Pravastatin Reduces Disease Activity and Inflammation in Dextran-Sulfate Induced Colitis J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 78 - 85. [Abstract] [Full Text] |
||||
![]() |
M. Nahrendorf, K. Hu, K.-H. Hiller, P. Galuppo, D. Fraccarollo, G. Schweizer, A. Haase, G. Ertl, W. R. Bauer, and J. Bauersachs Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: An experimental serial cardiac magnetic resonance imaging study J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1695 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adler, H. Huang, J. N. Trochu, X. Xu, S. Gupta, and T. H. Hintze Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure Am J Physiol Renal Physiol, November 1, 2001; 281(5): F802 - F809. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |